Exploring Gut Phages as a Defense Mechanism Against Drug-Resistant Bacterial Infections

Abstract

The human gut microbiota is a complex and dynamic ecosystem consisting of various microorganisms, including bacteria, viruses, fungi, and protozoa, that contribute to overall health. Among these, bacteriophages (phages) are viruses that specifically target and infect bacteria, playing a critical role in regulating microbial balance within the gut. In recent years, the rise of antibiotic-resistant bacterial infections has become a major global health challenge, largely attributed to the overuse and misuse of antibiotics. As a result, there has been growing interest in phages as a promising alternative to conventional antibiotics, particularly in combating drug-resistant infections. Phages offer several advantages, including their ability to selectively target specific bacteria, their rapid replication in the presence of host bacteria, and their potential to minimize disruption to the beneficial gut microbiota. Furthermore, phages may serve as a natural mechanism to restore microbial equilibrium in the gut, providing a novel strategy for treating infections that are difficult to manage with antibiotics. This manuscript examines recent research on gut phages, exploring their potential therapeutic applications, the mechanisms behind their bactericidal action, and their broader implications for human health, particularly in the context of rising antimicrobial resistance.